208 related articles for article (PubMed ID: 34664956)
1. Semimechanistic Population Pharmacokinetic Modeling to Investigate Amyloid Beta Trafficking and Accumulation at the BBB Endothelium.
Wang Z; Sharda N; Curran GL; Li L; Lowe VJ; Kandimalla KK
Mol Pharm; 2021 Nov; 18(11):4148-4161. PubMed ID: 34664956
[TBL] [Abstract][Full Text] [Related]
2. Distinct Uptake Kinetics of Alzheimer Disease Amyloid-
Sharda N; Ahlschwede KM; Curran GL; Lowe VJ; Kandimalla KK
J Pharmacol Exp Ther; 2021 Mar; 376(3):482-490. PubMed ID: 33303699
[TBL] [Abstract][Full Text] [Related]
3. Amyloid-Beta Peptides 40 and 42 Employ Distinct Molecular Pathways for Cell Entry and Intracellular Transit at the Blood-Brain Barrier Endothelium.
Wang Z; Sharda N; Omtri RS; Li L; Kandimalla KK
Mol Pharmacol; 2023 Nov; 104(5):203-213. PubMed ID: 37541759
[TBL] [Abstract][Full Text] [Related]
4. Traffic jam at the blood-brain barrier promotes greater accumulation of Alzheimer's disease amyloid-β proteins in the cerebral vasculature.
Agyare EK; Leonard SR; Curran GL; Yu CC; Lowe VJ; Paravastu AK; Poduslo JF; Kandimalla KK
Mol Pharm; 2013 May; 10(5):1557-65. PubMed ID: 23249146
[TBL] [Abstract][Full Text] [Related]
5. Age-Dependent Changes in the Plasma and Brain Pharmacokinetics of Amyloid-β Peptides and Insulin.
Zhou AL; Sharda N; Sarma VV; Ahlschwede KM; Curran GL; Tang X; Poduslo JF; Kalari KR; Lowe VJ; Kandimalla KK
J Alzheimers Dis; 2022; 85(3):1031-1044. PubMed ID: 34924382
[TBL] [Abstract][Full Text] [Related]
6. Insulin differentially affects the distribution kinetics of amyloid beta 40 and 42 in plasma and brain.
Swaminathan SK; Ahlschwede KM; Sarma V; Curran GL; Omtri RS; Decklever T; Lowe VJ; Poduslo JF; Kandimalla KK
J Cereb Blood Flow Metab; 2018 May; 38(5):904-918. PubMed ID: 28569090
[TBL] [Abstract][Full Text] [Related]
7. Differences in amyloid-β clearance across mouse and human blood-brain barrier models: kinetic analysis and mechanistic modeling.
Qosa H; Abuasal BS; Romero IA; Weksler B; Couraud PO; Keller JN; Kaddoumi A
Neuropharmacology; 2014 Apr; 79():668-78. PubMed ID: 24467845
[TBL] [Abstract][Full Text] [Related]
8. High-Density Lipoprotein Mimetic Peptide 4F Efficiently Crosses the Blood-Brain Barrier and Modulates Amyloid-
Swaminathan SK; Zhou AL; Ahlschwede KM; Curran GL; Lowe VJ; Li L; Kandimalla KK
J Pharmacol Exp Ther; 2020 Nov; 375(2):308-316. PubMed ID: 32778535
[TBL] [Abstract][Full Text] [Related]
9. Insulin Signaling Differentially Regulates the Trafficking of Insulin and Amyloid Beta Peptides at the Blood-Brain Barrier.
Zhou AL; Swaminathan SK; Salian VS; Wang L; Curran GL; Min HK; Lowe VJ; Kandimalla KK
Mol Pharm; 2024 May; 21(5):2176-2186. PubMed ID: 38625027
[TBL] [Abstract][Full Text] [Related]
10. Anti-malaria drug artesunate prevents development of amyloid-β pathology in mice by upregulating PICALM at the blood-brain barrier.
Kisler K; Sagare AP; Lazic D; Bazzi S; Lawson E; Hsu CJ; Wang Y; Ramanathan A; Nelson AR; Zhao Z; Zlokovic BV
Mol Neurodegener; 2023 Jan; 18(1):7. PubMed ID: 36707892
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
Shackleton B; Crawford F; Bachmeier C
Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
[TBL] [Abstract][Full Text] [Related]
12. Central role for PICALM in amyloid-β blood-brain barrier transcytosis and clearance.
Zhao Z; Sagare AP; Ma Q; Halliday MR; Kong P; Kisler K; Winkler EA; Ramanathan A; Kanekiyo T; Bu G; Owens NC; Rege SV; Si G; Ahuja A; Zhu D; Miller CA; Schneider JA; Maeda M; Maeda T; Sugawara T; Ichida JK; Zlokovic BV
Nat Neurosci; 2015 Jul; 18(7):978-87. PubMed ID: 26005850
[TBL] [Abstract][Full Text] [Related]
13. Mixed oligomers and monomeric amyloid-β disrupts endothelial cells integrity and reduces monomeric amyloid-β transport across hCMEC/D3 cell line as an in vitro blood-brain barrier model.
Qosa H; LeVine H; Keller JN; Kaddoumi A
Biochim Biophys Acta; 2014 Sep; 1842(9):1806-15. PubMed ID: 24997450
[TBL] [Abstract][Full Text] [Related]
14. Blood-brain-barrier models for the investigation of transporter- and receptor-mediated amyloid-β clearance in Alzheimer's disease.
Pflanzner T; Kuhlmann CR; Pietrzik CU
Curr Alzheimer Res; 2010 Nov; 7(7):578-90. PubMed ID: 20704558
[TBL] [Abstract][Full Text] [Related]
15. Magnesium Reduces Blood-Brain Barrier Permeability and Regulates Amyloid-β Transcytosis.
Zhu D; Su Y; Fu B; Xu H
Mol Neurobiol; 2018 Sep; 55(9):7118-7131. PubMed ID: 29383689
[TBL] [Abstract][Full Text] [Related]
16. Ketone Bodies Promote Amyloid-β
Versele R; Corsi M; Fuso A; Sevin E; Businaro R; Gosselet F; Fenart L; Candela P
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32023814
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's amyloid β heterogeneous species differentially affect brain endothelial cell viability, blood-brain barrier integrity, and angiogenesis.
Parodi-Rullán R; Ghiso J; Cabrera E; Rostagno A; Fossati S
Aging Cell; 2020 Nov; 19(11):e13258. PubMed ID: 33155752
[TBL] [Abstract][Full Text] [Related]
18. The concerted amyloid-beta clearance of LRP1 and ABCB1/P-gp across the blood-brain barrier is linked by PICALM.
Storck SE; Hartz AMS; Bernard J; Wolf A; Kachlmeier A; Mahringer A; Weggen S; Pahnke J; Pietrzik CU
Brain Behav Immun; 2018 Oct; 73():21-33. PubMed ID: 30041013
[TBL] [Abstract][Full Text] [Related]
19. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F
J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906
[TBL] [Abstract][Full Text] [Related]
20. Distinct Effects of Beta-Amyloid, Its Isomerized and Phosphorylated Forms on the Redox Status and Mitochondrial Functioning of the Blood-Brain Barrier Endothelium.
Petrovskaya AV; Tverskoi AM; Barykin EP; Varshavskaya KB; Dalina AA; Mitkevich VA; Makarov AA; Petrushanko IY
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
